Gennev is a pioneering entity in the Health Care and Women's Health sectors, established in 2016. Headquartered in the United States, the company operates as a virtual medical clinic specializing in menopausal care.
Their unique value proposition lies in offering services from menopause-trained MDs and Registered Dietitians. Patients can book appointments swiftly, often within a week. Gennev boasts that 89% of its patients experience symptom improvement after their initial consultation. They've strategically positioned themselves in-network with Aetna, enhancing accessibility to their services.
All resources and treatments are meticulously verified by physicians certified by The Menopause Society, ensuring the highest care quality. Despite notable achievements, the company's last publicly known funding event occurred on 01 February 2021, with no details on the investors disclosed.
Gennev epitomizes innovative health care solutions, addressing a specific, often underrepresented segment with significant impact potential in the industry.